生物瓣瓣环断裂辅助经导管瓣中瓣植入的体外研究
该体外台架测试评估了高压球囊对19mm和21mm多种外科生物瓣行瓣环断裂的可行性,发现Mitroflow、Magna、Magna Ease、Mosaic和Biocor Epic可成功断裂,而Trifecta和Hancock II不能。断裂仅累及瓣架,断裂压力8至24个大气压,且断裂有助于扩张先前受限的经导管瓣膜。
要点
- 多数但非所有外科主动脉生物瓣瓣架可经高压球囊断裂。
- 断裂仅累及内部瓣架,缝环未受损。
- 断裂有助于扩张先前受限的经导管瓣膜至推荐尺寸。
核心结论
- 台架测试表明多数但非全部外科主动脉生物瓣瓣架可使用高压球囊断裂。
- 生物瓣断裂优化小外科瓣瓣中瓣经导管主动脉瓣置换的安全性需进一步临床研究。
研究设计与样本
- 体外台架测试对19mm和21mm的Mitroflow、Magna、Magna Ease、Trifecta、Biocor Epic、Hancock II和Mosaic外科主动脉瓣进行测试。
- 使用Tru Dilation、Atlas Gold和Dorado高压球囊确定可断裂的瓣膜及断裂压力。
主要发现
- Mitroflow、Magna、Magna Ease、Mosaic和Biocor Epic外科瓣使用比标注尺寸大1mm的高压球囊成功断裂。
- Trifecta和Hancock II外科瓣未能断裂。
- 仅内部瓣架断裂,缝环从未受损。
- 断裂压力范围为8至24个大气压,取决于外科瓣类型,且超过了球囊的制造商额定爆破压。
- 断裂促进先前受限、扩张不足的经导管瓣膜(球囊扩张和自膨胀)扩张至制造商推荐尺寸。
关键数值与推荐
- 可断裂瓣膜:Mitroflow、Magna、Magna Ease、Mosaic、Biocor Epic。
- 不可断裂瓣膜:Trifecta、Hancock II。
- 断裂压力范围:8至24个大气压。
临床怎么用
- 在小外科瓣行瓣中瓣经导管主动脉瓣置换时,可考虑使用高压球囊行生物瓣断裂以促进经导管瓣膜扩张。
- 需注意并非所有外科瓣可断裂,且断裂压力可能超过球囊额定爆破压。
局限性
- 研究为体外台架测试,临床安全性和有效性需进一步临床研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Valve-in-valve transcatheter aortic valve replacement is less effective in small surgical bioprostheses. We evaluated the feasibility of bioprosthetic valve fracture with a high-pressure balloon to facilitate valve-in-valve transcatheter aortic valve replacement. METHODS: In vitro bench testing on aortic tissue valves was performed on 19-mm and 21-mm Mitroflow (Sorin, Milan, Italy), Magna and Magna Ease (Edwards Lifesciences, Irvine, CA), Trifecta and Biocor Epic (St. Jude Medical, Minneapolis, MN), and Hancock II and Mosaic (Medtronic, Minneapolis, MN). High-pressure balloons Tru Dilation, Atlas Gold, and Dorado (C.R. Bard, Murray Hill, NJ) were used to determine which valves could be fractured and at what pressure fracture occurred. RESULTS: Mitroflow, Magna, Magna Ease, Mosaic, and Biocor Epic surgical valves were successfully fractured using high-pressures balloon 1 mm larger than the labeled valve size whereas Trifecta and Hancock II surgical valves could not be fractured. Only the internal valve frame was fractured, and the sewing cuff was never disrupted. Manufacturer's rated burst pressures for balloons were exceeded, with fracture pressures ranging from 8 to 24 atmospheres depending on the surgical valve. Testing further demonstrated that fracture facilitated the expansion of previously constrained, underexpanded transcatheter valves (both balloon and self-expanding) to the manufacturer's recommended size. CONCLUSIONS: Bench testing demonstrates that the frame of most, but not all, bioprosthetic surgical aortic valves can be fractured using high-pressure balloons. The safety of bioprosthetic valve fracture to optimize valve-in-valve transcatheter aortic valve replacement in small surgical valves requires further clinical investigation.
引用
- Allen KB, Chhatriwalla AK, Cohen DJ, et al. Bioprosthetic Valve Fracture to Facilitate Transcatheter Valve-in-Valve Implantation. Ann Thorac Surg. 2017. PMID: 28669505. doi:10.1016/j.athoracsur.2017.04.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。